CAR10 up-regulated the expression of YB-1 by the direct binding and inhibition of its proteasomal degradation, resulting in an up-regulation of EGFR/pEGFR, pAKT and pERK, and a promotion of cancer cell proliferation in vitro and in vivo (Figure 3 to 7). Here, YBX1 is linked to cancer.